HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Progressive mental regression in siblings with Morquio disease type B (mucopolysaccharidosis IV B).

Abstract
A brother and sister with clinical and radiological features of Morquio disease, but with atypical mental regression, are described. Leucocyte and fibroblast beta-galactosidase activity was deficient in the siblings, while N-acetylgalactosamine 6-sulphate sulphatase and neuraminidase were normal. Study of the residual fibroblast beta-galactosidase activity towards 4-methylumbelliferyl and p-nitrophenyl beta-D-galactosides indicated that the mutation resembles that in typical Morquio B disease (increased Km and similar pH maximum) rather than that in GM1-gangliosidosis. The patients have therefore been classified as having Morquio B disease with atypical mental regression rather than GM1-gangliosidosis variants with particularly severe bony abnormalities. The mutation was, however, distinct from that in Morquio B disease since residual activity towards the alternative artificial substrate 4-methylumbelliferyl-beta-D-fucoside was increased. The patients represent further examples of the heterogeneity that can result from mutation at the beta-galactosidase locus.
AuthorsR Giugliani, M Jackson, S J Skinner, C M Vimal, A H Fensom, N Fahmy, A Sjövall, P F Benson
JournalClinical genetics (Clin Genet) Vol. 32 Issue 5 Pg. 313-25 (Nov 1987) ISSN: 0009-9163 [Print] Denmark
PMID3121219 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • beta-Galactosidase
Topics
  • Bone Diseases, Developmental (diagnostic imaging, enzymology, genetics)
  • Child
  • Chronic Disease
  • Diagnosis, Differential
  • Female
  • Humans
  • Intellectual Disability (enzymology, genetics)
  • Male
  • Mucopolysaccharidosis IV (enzymology, genetics)
  • Radiography
  • beta-Galactosidase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: